Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832610 · ClinicalTrials.gov registry record
Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 101
- Enrollment target
NCT01832610 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 101 participants.
The verdict
NCT01832610 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
Patients will be approached to participate in this PAS after the HeartWare® Ventricular Assist System receives PMA approval for the indicated use as a bridge to cardiac transplantation.
Interventions
- DEVICE HeartWare® VAS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01832610
The ClinicalTrials.gov registry entry for NCT01832610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HeartWare® VAS is the first listed.
NCT01832610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01832610 about?
NCT01832610 is a clinical study titled "Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials". Patients will be approached to participate in this PAS after the HeartWare® Ventricular Assist System receives PMA approval for the indicated use as a bridge to cardiac transplantation.
What is the current status of trial NCT01832610?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2013-01. Estimated completion is 2018-03.
What interventions are being tested in trial NCT01832610?
The interventions under investigation include: HeartWare® VAS (DEVICE).
Who is sponsoring clinical trial NCT01832610?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.